OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $108,000 | -88.6% | 534,900 | -27.2% | 0.01% | -90.4% |
Q4 2017 | $948,000 | -39.2% | 734,976 | 0.0% | 0.11% | -42.4% |
Q3 2017 | $1,558,000 | -26.9% | 734,976 | 0.0% | 0.20% | -40.2% |
Q2 2017 | $2,131,000 | -15.7% | 734,976 | 0.0% | 0.33% | -23.0% |
Q1 2017 | $2,528,000 | +97.7% | 734,976 | 0.0% | 0.43% | +67.3% |
Q4 2016 | $1,279,000 | -47.6% | 734,976 | 0.0% | 0.26% | -44.1% |
Q3 2016 | $2,440,000 | – | 734,976 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 622,013 | $2,140,000 | 0.92% |
Foresite Capital Management III, LLC | 380,530 | $1,309,000 | 0.50% |
BVF INC/IL | 734,976 | $2,528,000 | 0.43% |
Old West Investment Management, LLC | 206,687 | $711,000 | 0.38% |
Telemetry Investments, L.L.C. | 88,269 | $304,000 | 0.14% |
EcoR1 Capital, LLC | 117,726 | $405,000 | 0.10% |
Baupost Group | 2,226,839 | $7,660,000 | 0.09% |
Rhenman & Partners Asset Management AB | 120,000 | $413,000 | 0.06% |
GLG LLC | 250,172 | $861,000 | 0.05% |
NEA Management Company, LLC | 370,900 | $1,276,000 | 0.04% |